Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
67.28
1.74 (2.65%)
At close: Aug 15, 2025, 3:59 PM
67.50
0.33%
After-hours: Aug 15, 2025, 07:58 PM EDT
Halozyme Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.18B | 1.08B | 1.02B | 947.36M | 873.3M | 862.99M | 829.25M | 780.71M | 773.65M | 704.98M | 660.12M | 580.62M | 487.48M | 471.57M | 443.31M | 463.01M | 412.5M | 331.26M |
Cost of Revenue | 186.24M | 197.25M | 194.94M | 205.19M | 210.58M | 203.28M | 192.36M | 182.18M | 174.68M | 158.55M | 139.3M | 118.77M | 90.04M | 79.12M | 81.41M | 86.1M | 73.08M | 55.8M |
Gross Profit | 992.43M | 887.05M | 820.38M | 742.17M | 662.72M | 659.71M | 636.89M | 598.53M | 598.97M | 546.43M | 520.81M | 461.85M | 397.44M | 392.45M | 361.9M | 376.91M | 339.42M | 275.46M |
Operating Income | 682.67M | 597.47M | 551.48M | 477.01M | 402.09M | 379.31M | 337.57M | 311.05M | 306.06M | 245.66M | 267.53M | 249.56M | 241.85M | 300.84M | 275.9M | 296.99M | 261.7M | 198.21M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 692.13M | 604.93M | 557.13M | 480.09M | 416.71M | 392.12M | 348.33M | 317.94M | 289.89M | 226.75M | 248.92M | 232.94M | 233.34M | 294.84M | 248.52M | 266.96M | 229.12M | 163.48M |
Net Income | 557.28M | 485.36M | 444.09M | 392.47M | 337.29M | 318.8M | 281.59M | 253.91M | 233.71M | 181.64M | 202.13M | 211.2M | 366.15M | 434.92M | 402.71M | 409.1M | 228.72M | 163.08M |
Selling & General & Admin | 167.47M | 161.56M | 154.34M | 149.69M | 143.72M | 146.96M | 149.18M | 149.32M | 148.52M | 167.05M | 143.53M | 119.55M | 98.25M | 53.1M | 50.32M | 46.98M | 45.51M | 44.16M |
Research & Development | 71.24M | 74.74M | 79.05M | 79.94M | 78.81M | 77.5M | 76.36M | 77.59M | 76.98M | 72.73M | 66.61M | 54.15M | 45.93M | 38.52M | 35.67M | 32.94M | 32.2M | 33.09M |
Other Expenses | 71.05M | 53.29M | 35.52M | 35.52M | 38.1M | 55.94M | 73.77M | 60.56M | 67.42M | 60.98M | 43.15M | 38.6M | 11.4M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 309.75M | 289.58M | 268.91M | 265.16M | 260.63M | 280.39M | 299.32M | 287.48M | 292.91M | 300.76M | 253.28M | 212.3M | 155.59M | 91.61M | 86M | 79.92M | 77.71M | 77.25M |
Interest Expense | 17.98M | 18.11M | 18.09M | 18.77M | 18.76M | 18.73M | 18.76M | 18.11M | 21.12M | 19.73M | 16.95M | 14.43M | 8.67M | 7.32M | 7.53M | 10.51M | 13.74M | 17M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.21M | -2.21M | -2.21M |
Cost & Expenses | 496M | 486.84M | 463.85M | 470.35M | 471.21M | 483.68M | 491.68M | 469.66M | 467.59M | 459.32M | 392.58M | 331.07M | 245.63M | 170.73M | 167.41M | 166.02M | 150.79M | 133.05M |
Income Tax Expense | 134.85M | 119.57M | 113.04M | 87.63M | 79.41M | 73.32M | 66.73M | 64.04M | 56.19M | 45.11M | 46.79M | 21.74M | -132.81M | -140.08M | -154.19M | -142.15M | 397K | 397K |
Shares Outstanding (Basic) | 121.34M | 123.22M | 126.41M | 126.85M | 127.12M | 126.94M | 129.05M | 131.97M | 131.73M | 135.03M | 135.28M | 136.53M | 137.94M | 137.66M | 140.22M | 142.02M | 142.49M | 137.95M |
Shares Outstanding (Diluted) | 124.16M | 126.64M | 129.42M | 130.13M | 129.22M | 128.89M | 131.03M | 134.08M | 133.54M | 137.9M | 138.6M | 139.39M | 142.22M | 141.28M | 144.25M | 146.69M | 147.62M | 148.54M |
EPS (Basic) | 4.48 | 3.85 | 3.50 | 3.08 | 2.62 | 2.46 | 2.14 | 1.91 | 1.74 | 1.33 | 1.48 | 1.53 | 2.61 | 3.09 | 2.85 | 2.91 | 1.65 | 1.20 |
EPS (Diluted) | 4.37 | 3.76 | 3.43 | 3.02 | 2.58 | 2.42 | 2.11 | 1.88 | 1.71 | 1.31 | 1.45 | 1.49 | 2.53 | 2.99 | 2.75 | 2.79 | 1.56 | 1.13 |
EBITDA | 791.84M | 699.6M | 646.55M | 570.47M | 509.74M | 490.43M | 451.92M | 407.3M | 388.41M | 315.75M | 314.95M | 290.12M | 256.26M | 304.71M | 279.74M | 301.19M | 266.69M | 204.3M |
EBIT | 710.11M | 618.01M | 565.2M | 488.84M | 425.44M | 405.85M | 367.09M | 336.06M | 311.01M | 246.48M | 265.37M | 246.87M | 241.24M | 301.17M | 276.23M | 297.65M | 263.33M | 201.16M |
Depreciation & Amortization | 81.73M | 81.59M | 81.34M | 81.62M | 84.3M | 84.58M | 84.83M | 71.25M | 77.4M | 69.27M | 49.59M | 43.25M | 14.75M | 3.05M | 3.01M | 3.04M | 3.14M | 3.17M |